As part of this project, the NMI will use differential serolomics to assess seroprevalence, cross-immunity, and pre-existing immunity to coronaviruses.
Patient-derived microtumors (PDM) and autologous immune cells from tumor tissue will be treated with chemo- and immunotherapeutic agents, followed by proteo-genomic single cell analysis and generation
Oops, an error occurred! Code: 202310161030081f8b0abd
CAR-T cells are expected to revolutionize cancer therapy. CAR-T cells are expected to revolutionize cancer therapy. In order to obtain these helpers in the future more cost-effectively than before and
Dr. Dagmar Martin in an interview. Why are surfaces so important in medical technology and what challenges await us? Take a look at the exciting interview by microTEC Südwest e.V. on the work of Dr. D
For the implementation of personalized oncology, it is crucial to develop tumor models that allow individualized validation of cancer therapies that are particularly effective in each case. For the im
After 4 years it was finally time again - the NMI in Reutlingen invited the network of microelectrode array (MEA) developers and users to Tübingen for the MEA Conference 2022. After 4 years it was fin
KMU-innovativ - Joint project: Pancreas implant for blood glucose monitoring (PanaMEA) - Subproject: Pancreas interface
RegioWIN Lighthouse Project LTP1: Establishment of a research and service center for high-resolution nanoanalytics Establishment of a research and service center for high-resolution nanoanalytics In 2
Material and Surface Analysis Often, just a few atomic layers determine whether a surface is water-repellent, adhesive, paintable or antibacterial. Targeted modification can give surfaces of many subs
